Anthera Pharmaceuticals is a biopharmaceutical company that specializes in products to treat serious diseases associated with inflammation and autoimmune diseases. The company has two product candidates in development. Sollpura is a biotechnology-derived pancreatic enzyme replacement therapy for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis. Blisibimod is a BAFF inhibitor for the potential treatment of IgA nephropathy. The company was founded in 2004 and is headquartered in Hayward, California.